ArticleArthritis & rheumatology (Hoboken, N.J.)2025

Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification Criteria.

Remco G A Erkens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.